BMY

NYSE · Pharmaceuticals

Bristol-Myers Squibb Co

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield

$63.13

-1.06 (-1.65%)

Analyst Consensus

Hold

Analysts

Very High

Coverage

Buy 15 44%

Hold 18 53%

Sell 1 3%

Price Target

Analyst Price Target +176.4% upside

Low Target $130.78

Average Target $174.50

High Target $195.10

Current Price $63.13

Current
$63.13

Target
$174.50

$130.78 $174.50 avg $195.10

Scenario Analysis

Bear Case

$130.78

107.2%

Low target

Base Case

$174.50

+176.4%

Avg target

Bull Case

$195.10

+209.0%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$68.64

-8.0% from high

52-Week Low

$42.52

+48.5% from low

50-Day SMA

$62.53

+1.0% vs SMA

200-Day SMA

$60.06

+5.1% vs SMA

RSI (14)

61.3

Neutral

Target vs 52W High

$174.50

+154.2% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	36	86%	$1,330.33	-2.5%
RDY Dr. Reddy's Laboratories	Sell	42	45%	—	+0.0%
JNJ Johnson & Johnson	Buy	30	73%	$299.55	+10.0%
MRK Merck & Co. Inc.	Buy	35	74%	$159.27	+8.4%
PFE Pfizer Inc.	Hold	33	39%	$33.90	+13.5%
BMY Bristol-Myers Squibb Co	Hold	34	44%	$174.50	+176.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	14	93%	$36.26	-46.3%
ZTS Zoetis Inc	Hold	23	48%	$209.87	+155.6%